Allergie Bronchopulmonary Aspergillosis: A Review

Autor: Andrew Wardlaw, Dm, Geddes

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0f55a378fb7f324a1e87b43df2306c8
https://doi.org/10.1177/014107689208501212

Effect of heart-lung transplantation on airway potential difference in patients with and without cystic fibrosis

Autor: EW Alton, A Khagani, RF Taylor, R Logan-Sinclair, M Yacoub, DM Geddes

Publikováno v: European Respiratory Journal. 4:5-9

Measurement of the potential difference (PD) across the airways provides an indication of the viability and integrity of the lining epithelium. PD was recorded from the lower airways in "diseased controls" and in patients following heart-lung transpl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3f60b8cdfce588853b3bd90d59671490
https://doi.org/10.1183/09031936.93.04010005

Nasal potential difference: a clinical diagnostic test for cystic fibrosis

Autor: EW Alton, D Currie, R Logan-Sinclair, JO Warner, ME Hodson, DM Geddes

Publikováno v: The European respiratory journal. 3(8)

Patients with cystic fibrosis (CF) demonstrate a markedly more negative potential difference (PD) across respiratory epithelia than normal or "diseased" controls. A technique is described for the measurement of nasal PD in both children and adults. 1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8e9c0ad16260be2c5c4019992e6923d
https://pubmed.ncbi.nlm.nih.gov/2292287

Respiratory aspects of Shwachman's syndrome in adults

Autor: J Wiggins, DM Geddes

Publikováno v: European Respiratory Journal. 2:285-288

Shwachman's Syndrome is a rare disorder which causes considerable morbidity in childhood and can be confused with cystic fibrosis. Six patients (4 males; mean age 27 yrs) are described in order to illustrate the clinical picture of the syndrome in ad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e573d90e4130789475149be351ad9133
https://doi.org/10.1183/09031936.93.02030285

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.

Autor: Alton EWFW; Imperial College London, London, UK. Electronic address: e.alton@imperial.ac.uk., Armstrong DK; Royal Hospital for Sick Children, Edinburgh, UK., Ashby D; Imperial College London, London, UK., Bayfield KJ; Imperial College London, London, UK., Bilton D; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Bloomfield EV; Imperial College London, London, UK., Boyd AC; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Brand J; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Buchan R; Western General Hospital, Edinburgh, UK., Calcedo R; Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Carvelli P; Imperial College London, London, UK., Chan M; Imperial College London, London, UK., Cheng SH; Genzyme, a Sanofi Company, Framingham, MA, USA., Collie DDS; The Roslin Institute and R(D)SVS, University of Edinburgh, Edinburgh, UK., Cunningham S; Royal Hospital for Sick Children, Edinburgh, UK., Davidson HE; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Davies G; Imperial College London, London, UK., Davies JC; Imperial College London, London, UK., Davies LA; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Dewar MH; Western General Hospital, Edinburgh, UK., Doherty A; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Donovan J; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Dwyer NS; Imperial College London, London, UK., Elgmati HI; Western General Hospital, Edinburgh, UK., Featherstone RF; Imperial College London, London, UK., Gavino J; Imperial College London, London, UK., Gea-Sorli S; Imperial College London, London, UK., Geddes DM; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Gibson JSR; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Gill DR; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Greening AP; Western General Hospital, Edinburgh, UK., Griesenbach U; Imperial College London, London, UK., Hansell DM; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Harman K; Imperial College London, London, UK., Higgins TE; Imperial College London, London, UK., Hodges SL; Imperial College London, London, UK., Hyde SC; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Hyndman L; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Innes JA; Western General Hospital, Edinburgh, UK., Jacob J; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Jones N; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Keogh BF; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Limberis MP; Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lloyd-Evans P; NHS Blood and Transplant, Bristol, UK., Maclean AW; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Manvell MC; Imperial College London, London, UK., McCormick D; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., McGovern M; Western General Hospital, Edinburgh, UK., McLachlan G; The Roslin Institute and R(D)SVS, University of Edinburgh, Edinburgh, UK., Meng C; Imperial College London, London, UK., Montero MA; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Milligan H; Western General Hospital, Edinburgh, UK., Moyce LJ; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Murray GD; Usher Institute of Population Health Sciences and Informatics and Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK., Nicholson AG; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Osadolor T; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Parra-Leiton J; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Porteous DJ; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Pringle IA; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Punch EK; Imperial College London, London, UK., Pytel KM; Imperial College London, London, UK., Quittner AL; University of Miami, Miami, FL, USA., Rivellini G; Imperial College London, London, UK., Saunders CJ; Imperial College London, London, UK., Scheule RK; Genzyme, a Sanofi Company, Framingham, MA, USA., Sheard S; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Simmonds NJ; Royal Brompton and Harefield NHS Foundation Trust, London, UK., Smith K; NHS Blood and Transplant, Bristol, UK., Smith SN; Imperial College London, London, UK., Soussi N; Imperial College London, London, UK., Soussi S; Imperial College London, London, UK., Spearing EJ; Imperial College London, London, UK., Stevenson BJ; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK., Sumner-Jones SG; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Turkkila M; Imperial College London, London, UK., Ureta RP; Imperial College London, London, UK., Waller MD; Imperial College London, London, UK., Wasowicz MY; Imperial College London, London, UK., Wilson JM; Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wolstenholme-Hogg P; Genzyme, a Sanofi Company, Framingham, MA, USA.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2015 Sep; Vol. 3 (9), pp. 684-691. Date of Electronic Publication: 2015 Jul 03.